Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 7 | 2021 | 282 | 1.820 |
Why?
|
| Bacteremia | 3 | 2019 | 101 | 1.170 |
Why?
|
| Intensive Care Units | 3 | 2024 | 306 | 0.940 |
Why?
|
| Critical Care | 2 | 2023 | 199 | 0.850 |
Why?
|
| Chlorhexidine | 2 | 2023 | 57 | 0.780 |
Why?
|
| Infection Control | 3 | 2021 | 166 | 0.720 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 116 | 0.600 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 18 | 0.590 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 158 | 0.590 |
Why?
|
| Baths | 1 | 2018 | 25 | 0.580 |
Why?
|
| Catheter-Related Infections | 1 | 2015 | 20 | 0.470 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 35 | 0.470 |
Why?
|
| Adult | 9 | 2024 | 8107 | 0.350 |
Why?
|
| Child Health Services | 1 | 2008 | 12 | 0.290 |
Why?
|
| Child Welfare | 1 | 2008 | 20 | 0.290 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 58 | 0.290 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 24 | 0.290 |
Why?
|
| Klebsiella Infections | 2 | 2019 | 55 | 0.290 |
Why?
|
| Klebsiella pneumoniae | 2 | 2019 | 60 | 0.290 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 78 | 0.290 |
Why?
|
| beta-Lactamases | 2 | 2019 | 85 | 0.280 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 111 | 0.270 |
Why?
|
| Urban Population | 1 | 2008 | 156 | 0.270 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2024 | 59 | 0.260 |
Why?
|
| Feedback | 1 | 2023 | 33 | 0.210 |
Why?
|
| Humans | 11 | 2024 | 28435 | 0.210 |
Why?
|
| Male | 8 | 2024 | 15292 | 0.200 |
Why?
|
| Female | 8 | 2024 | 15728 | 0.190 |
Why?
|
| Health Personnel | 2 | 2021 | 107 | 0.190 |
Why?
|
| Chicago | 3 | 2024 | 947 | 0.180 |
Why?
|
| Risk Factors | 3 | 2017 | 2408 | 0.180 |
Why?
|
| Middle Aged | 6 | 2024 | 9270 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 133 | 0.160 |
Why?
|
| Aged | 6 | 2024 | 9278 | 0.160 |
Why?
|
| Protective Clothing | 1 | 2019 | 9 | 0.160 |
Why?
|
| Equipment Contamination | 1 | 2019 | 24 | 0.160 |
Why?
|
| Medical Errors | 1 | 2019 | 28 | 0.160 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 67 | 0.160 |
Why?
|
| Skin Care | 1 | 2018 | 12 | 0.150 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2018 | 46 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 500 | 0.140 |
Why?
|
| Skin | 1 | 2018 | 116 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 181 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2017 | 110 | 0.130 |
Why?
|
| Poisson Distribution | 1 | 2015 | 22 | 0.130 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 31 | 0.130 |
Why?
|
| Hospitals, Public | 1 | 2015 | 25 | 0.120 |
Why?
|
| Urban Health Services | 1 | 2015 | 14 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 32 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 68 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 19 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2015 | 123 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 97 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2015 | 109 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2015 | 358 | 0.110 |
Why?
|
| Young Adult | 2 | 2019 | 2070 | 0.100 |
Why?
|
| Rectum | 2 | 2024 | 51 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2021 | 3612 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 383 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3616 | 0.080 |
Why?
|
| Medical Assistance | 1 | 2008 | 3 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2008 | 13 | 0.070 |
Why?
|
| Carbapenems | 2 | 2019 | 39 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 23 | 0.070 |
Why?
|
| Hospitals | 2 | 2019 | 156 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 310 | 0.070 |
Why?
|
| Social Support | 1 | 2008 | 217 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4857 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2008 | 677 | 0.060 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2024 | 11 | 0.060 |
Why?
|
| Epidemiological Monitoring | 1 | 2024 | 13 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 60 | 0.060 |
Why?
|
| Carrier State | 1 | 2024 | 55 | 0.060 |
Why?
|
| Feces | 1 | 2024 | 113 | 0.060 |
Why?
|
| Child | 1 | 2008 | 1421 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2024 | 168 | 0.050 |
Why?
|
| United States | 1 | 2008 | 2200 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2021 | 22 | 0.050 |
Why?
|
| Pancreas | 1 | 2021 | 33 | 0.050 |
Why?
|
| Genomics | 1 | 2021 | 58 | 0.050 |
Why?
|
| Kidney | 1 | 2021 | 175 | 0.040 |
Why?
|
| Gloves, Protective | 1 | 2019 | 15 | 0.040 |
Why?
|
| Hand Disinfection | 1 | 2019 | 24 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 145 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 773 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 352 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2017 | 58 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 594 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1809 | 0.030 |
Why?
|